A novel role of circCPSF6 regulating antiviral innate immunity via miR-665 and PCBP2-IPS-1 axis
Meher, A.; Chaudhary, R.; Kumar, H.
Show abstract
ObjectiveCircular RNAs are emerging as critical regulators of biological processes, yet their contribution to innate immune response during virus infection remains insufficiently defined. This study investigated the role of circCPSF6 in modulating host antiviral responses. MethodCircCPSF6 expression was validated in human and murine cells and tissue by RT-PCR and digital PCR. Its effect on virus replication was analysed by RT-PCR in human and murine primary cells and cytokine production at protein level was measured by ELISA. Luciferase assay, RNA immunoprecipitation, RNA pulldown assay, immunoblotting was performed to explore the circRNA-miRNA regulatory mechanism. CircCPSF6 interacting protein were identified by RNA pulldown followed by mass spectrometry and regulatory mechanism was analysed by immunoblotting and confocal microscopy. ResultCircCPSF6 identified as highly conserved circRNA, suppressed during virus infection, in vitro and in vivo. Functional analyses revealed antiviral role of circCPSF6. Mechanistically, circCPSF6 has dual cross-regulatory role by sequestering proviral miR-665 to relieve expression of key antiviral genes (MyD88, STAT2, IKK{varepsilon}) and interact with RNA binding protein PCBP2 to modulate IPS-1 degradation. ConclusionCircCPSF6 exert antiviral role and regulate host innate immune signaling by direct RNA-RNA and RNA-protein interaction, highlights circRNA mediated network as a potential therapeutic target in virus infection. HighlightsCircCPSF6 is evolutionarily conserved and suppressed during virus infection. CircCPSF6 act as antiviral factor by promoting inflammatory cytokine production. CircCPSF6 sponges proviral miR-665 and alleviate MyD88, STAT2, IKK{varepsilon} expression. CircCPSF6 bind to PCBP2, limit IPS-1 degradation and sustain antiviral signaling. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=151 SRC="FIGDIR/small/686289v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@f59bedorg.highwire.dtl.DTLVardef@cff26eorg.highwire.dtl.DTLVardef@354ea5org.highwire.dtl.DTLVardef@1be4c63_HPS_FORMAT_FIGEXP M_FIG Mechanism of host innate immune regulation by circCPSF6 during virus infection. In cell cytoplasm circCPSF6 act as ceRNA for miR-665 and RNA binding protein PCBP2. Virus infection leads to reduced circCPSF6 and increased miR-665 expression, which inhibits expression of antiviral genes, MyD88, STAT2, IKK{varepsilon}. Additionally, reduced circCPSF6 leads to elevated free PCBP2 protein, hence, promote PCBP2 mediated IPS-1 degradation. Overall, these effects contribute to reduced innate immune response and increased viral replication. C_FIG
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The genetic driver of Acute Necrotizing Encephalopathy, RANBP2, regulates the inflammatory response to Influenza A virus infection 96%
- Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 95%
- A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models 95%
Similar papers in this journal
- RTN3 inhibits RIGI-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination 96%
- ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation 96%
- An arms race between 5'ppp-RNA virus and its alternative recognition receptor MDA5 in RIG-I-lost teleost fish 96%
Similar papers in this journal
- The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity 95%
- Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia 95%
- Integrated role of microRNA-30e-5p through targeting negative regulators of innate immune pathways during HBV infection and SLE 95%
Similar papers in this journal
- Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2 94%
- Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell 94%
- Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting 94%
Similar papers in this journal
- SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication 95%
- Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response 94%
- Retinoic Acid Inducible Gene-I like Receptors Activate Snail and Slug to Limit RNA Viral Infections 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.